You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 4, Oct 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Synthetic Estrogens in Treatment of Atherosclerosis

A Study of Prostatic Cancer Patients

GEORGE F. MEISSNER, M.D.; CONSTANCE M. MOEHRING, B.S.

Arch Intern Med. 1962;110(4):467-471.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Prostatic cancer patients were studied from the following aspects: (1) periodic lipid determinations, (2) gross and microscopic study of coronary arteries and aortae in a small number of autopsied cases, (3) retrospective review of 100 autopsy records of prostatic cancer patients, and (4) screening tests of blood coagulation in selected cases.

Except for serum lipid changes as reported by many investigators1,2 no unequivocal effect on arteries or blood coagulation was demonstrated which could be ascribed to estrogen therapy.

Materials and Methods

A. Serum lipids3-6 were determined in a group of 64 presumably healthy male subjects from 60-90 years of age actively employed in the hospital (Table). In 25 subjects the "individual biologic variation" was determined as the standard deviation of the mean obtained by 4 lipid determinations (in the same individual) several weeks to months apart; the average value multiplied by 37 was considered an individual's biologic . . . [Full Text PDF of this Article]


Author Affiliations

PROVIDENCE, R.I.

From the Institute of Pathology, Rhode Island Hospital.


Footnotes

Submitted for publication April 23, 1962; accepted June 25.

This study was supported by grants of the Rhode Island Heart Association and was presented in part at the American Heart Association meetings, October, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.